A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
Children's Oncology Group
Children's Oncology Group
Northside Hospital, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Canadian Cancer Trials Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Alliance for Clinical Trials in Oncology
University of Chicago
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
City of Hope Medical Center
Fred Hutchinson Cancer Center
Incyte Corporation
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ruijin Hospital
Institute of Hematology & Blood Diseases Hospital, China
M.D. Anderson Cancer Center
Henan Cancer Hospital
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Sanofi
University of Cologne
Institute of Hematology & Blood Diseases Hospital, China
University of Miami
International Extranodal Lymphoma Study Group (IELSG)
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Second Affiliated Hospital of Soochow University
Janssen Research & Development, LLC
Peking Union Medical College Hospital
Instituto do Cancer do Estado de São Paulo
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
International Extranodal Lymphoma Study Group (IELSG)